Biogen Idec-BIIB option implied volatility at high end of range into Tysabri FDA committee
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) : BIIB & ELN's Tysabri for multiple sclerosis will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
